detox

Phases of liver detox: glucuronidation, sulfation, methylation, and taurine conjugation

Phase I and Phase II aren't marketing terms — they're specific biochemical steps your liver runs to clear drugs, hormones, and environmental toxins. Here's what drives glucuronidation, sulfation, methylation, and taurine conjugation, and where the pathway typically gets stuck.

By Gene Direct Editorial April 7, 2026 6 min read

“Detox” is one of the most overused words in wellness. It also happens to describe something real: a multi-step biochemical pipeline your liver runs every second, converting fat-soluble drugs, hormones, and environmental compounds into water-soluble metabolites your body can excrete.

That pipeline has structure. It runs in phases. Each phase has distinct enzymes, distinct nutrient requirements, and distinct ways of failing. Understanding that structure is the difference between a thoughtful protocol and a cleanse tea.

The architecture: three phases, one pipeline

Modern pharmacology texts describe drug metabolism in three connected phases:12

  • Phase I — chemical modification. Enzymes (mostly cytochrome P450) oxidize, reduce, or hydrolyze a compound, usually adding or exposing a reactive group.
  • Phase II — conjugation. Enzymes attach a water-soluble molecule (glutathione, glucuronide, sulfate, glycine, acetyl, methyl) to the Phase I intermediate, making it excretable.
  • Phase III — transport. Membrane transporters pump the conjugated metabolite out of the hepatocyte into bile or back into circulation for kidney excretion.

The system evolved to handle xenobiotics — foreign molecules — but it also metabolizes steroid hormones, neurotransmitters, and endogenous signaling compounds. When any phase runs poorly, the effects ripple well beyond “feeling toxic.”

Phase I: the cytochrome P450 system

The cytochrome P450 (CYP) enzyme family does most of Phase I. About a dozen CYP enzymes in the CYP1, CYP2, and CYP3 families handle 70–80% of clinically used drug metabolism, with CYP3A4 alone metabolizing roughly half of all pharmaceuticals.2

Phase I is a chemistry change, not a finished removal. The modified compound is often more reactive than the original. That’s biochemically normal — it primes the molecule for Phase II conjugation — but it also means Phase I without sufficient Phase II capacity generates a temporary buildup of reactive intermediates.

Phase I cofactor demand:

  • Riboflavin (B2) — FAD-dependent reactions
  • Niacin (B3) — NADPH, the reducing power that drives CYP reactions
  • Iron — structural component of the heme group inside CYP
  • Magnesium, zinc, copper — cofactors for various Phase I sub-reactions
  • Glutathione — quenches reactive intermediates produced during oxidation

CYP activity is also modulated by what you eat. Cruciferous vegetables (sulforaphane), resveratrol, and grape-seed polyphenols alter CYP expression. Grapefruit juice famously inhibits CYP3A4 — which is why medications list it as a caution.

Phase II: conjugation — where most people stall

Phase II takes the reactive Phase I intermediate and attaches a water-soluble “handle.” Six major conjugation routes run in parallel, and each uses a specific nutrient currency:12

1. Glutathione conjugation

Glutathione S-transferases (GSTs) bind reduced glutathione to electrophilic compounds — the route for acetaminophen overflow, heavy metals, and many environmental toxins. Requires cysteine, glycine, glutamate, magnesium, ATP. Bottleneck for most patients with chronic toxin exposure.3 Learn more about glutathione.

2. Glucuronidation

UDP-glucuronosyltransferases (UGTs) attach glucuronic acid. Handles bilirubin, thyroid hormones, many drugs, and hormone metabolites. Requires adequate glucose, magnesium, and UDP-glucuronic acid; supported by B vitamins and calcium D-glucarate.

3. Sulfation

Sulfotransferases (SULTs) attach a sulfate group. Handles estrogens, neurotransmitters, thyroid hormones, phenolic compounds. Requires cysteine-derived sulfate, molybdenum, vitamin B6.

4. Methylation

Catechol-O-methyltransferase (COMT) and other methyltransferases attach a methyl group from S-adenosylmethionine (SAM). Handles catecholamines (dopamine, norepinephrine), estrogens, histamine, some drugs. Requires methionine, 5-MTHF, methyl-B12, B6. This is where the methylation cycle intersects directly with detoxification.

5. Acetylation

N-acetyltransferases (NAT1, NAT2) attach an acetyl group. Handles caffeine, certain drugs, biogenic amines. Requires pantothenic acid (B5, the source of acetyl-CoA), molybdenum.

6. Amino acid conjugation

Glycine, taurine, and glutamine are conjugated to various acids. Requires adequate amino acid pools and B5.

Each route uses different nutrients, which is why a single-nutrient “detox pill” rarely solves a stuck pathway — the patient’s actual bottleneck might be in a different route entirely.

Q: What happens when Phase II can’t keep up with Phase I?

A: You get accumulation of reactive Phase I intermediates — the compounds the system meant to briefly produce before conjugating them out. These intermediates can drive oxidative stress, deplete glutathione, and generate the symptom patterns sometimes called “toxin backlog” (sluggishness, skin reactions, sensitivity to smells and alcohol, slow clearance of medication). Balanced detox support means both phases are adequately nourished — speeding Phase I without Phase II support often makes things worse.

Where the methylation cycle fits in

Methylation is one of the six Phase II routes, but it’s also upstream of another one (glutathione conjugation) through the transsulfuration pathway. That gives methylation outsized influence over detox capacity.

Three specific intersections:

  • Catechol clearance. COMT uses SAM to methylate catecholamines (dopamine, norepinephrine, epinephrine) and estrogen metabolites. Slow COMT variants — common in roughly 25% of the population — can feed back into mood and stress symptoms when methyl donors run low.
  • Glutathione production. Homocysteine leaving the methylation cycle enters transsulfuration, which produces cysteine — the rate-limiting precursor for GSH.
  • Histamine metabolism. HNMT methylates histamine in the CNS; deficits show up as histamine intolerance when methylation is under-resourced.

For patients with confirmed MTHFR variants or functional undermethylation, supporting the methylation arm of detox is non-negotiable. Methylation Complete™ delivers the activated B-vitamin trio (5-MTHF, methylcobalamin B12, P5P B6); Methyl Folate Plus™ supplies higher-dose 5-MTHF plus folinic acid and B2 for patients with confirmed variants or higher clinical need.

Phase III: the forgotten phase

Phase III is the transport step — proteins like MRP2 and P-glycoprotein that pump conjugated metabolites out of hepatocytes into bile. This phase depends on:

  • Adequate bile flow — cholagogues like taurine, dandelion root, and beet support
  • Membrane integrity — choline, phosphatidylcholine
  • Gut function — conjugated toxins excreted in bile need to actually leave the body, not be reabsorbed. A healthy microbiome and adequate fiber bind and remove them.

A common failure pattern: Phases I and II run, but constipation, dysbiosis, or bile sludge means conjugated metabolites circulate back through enterohepatic recirculation. The detox happens, but the exit doesn’t.

Where genetics enter the picture

Phase I and Phase II enzymes show substantial genetic variation. Common clinically relevant SNPs include:

  • CYP1A2 — caffeine metabolism (fast vs. slow metabolizers)
  • CYP2D6 — many psychiatric medications
  • CYP3A4/5 — statins, hormones, many drugs
  • COMT Val158Met — catechol and estrogen methylation speed
  • GSTM1, GSTT1 — glutathione conjugation; null variants (full gene deletion) are common
  • NAT2 — acetylation (slow vs. fast acetylator)
  • SULT1A1 — sulfation capacity

Standard lab panels don’t look at these. A comprehensive nutrigenomic panel maps all of them in one report, letting a practitioner match support to the specific bottlenecks in your chemistry.

The short version

  • Detoxification runs in three linked phases: Phase I modifies, Phase II conjugates, Phase III transports out.
  • Each phase depends on specific cofactors; each can fail independently.
  • Methylation is both a Phase II route itself (COMT, HNMT) and upstream of glutathione synthesis — making it a high-leverage point for detox support.
  • Genetic variation in CYP, GST, COMT, and related enzymes determines where your specific bottleneck is.
  • Supporting detox thoughtfully means nourishing both phases, supporting elimination (Phase III), and looking at the genes underneath when the pattern is persistent.

If methylation is the upstream constraint, Methylation Complete™ or Methyl Folate Plus™ provide the bioactive B-vitamin inputs. For a full-system picture — detox, methylation, and every other wellness-relevant gene family — GenePro+ is the starting point.


References


This article is educational and does not constitute medical advice. Detoxification protocols should be individualized and reviewed with a qualified healthcare provider, especially if you take prescription medications or are pregnant.

Footnotes

  1. Almazroo OA, Miah MK, Venkataramanan R. Drug Metabolism in the Liver. Clin Liver Dis. 2017. PMID: 27842765 2

  2. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013. PMID: 23333322 2 3

  3. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 2007. PMID: 18158646

#detox #liver #cytochrome-p450 #glutathione #methylation

Related reading

← All articles Gene Direct Nutrition publishes clinical-grade education reviewed for accuracy. This article is educational and not medical advice.